These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15918553)
1. Cerebrospinal fluid neurone-specific enolase in mitochondrial encephalomyopathies. Finsterer J; Exner M; Rumpold H Metab Brain Dis; 2005 Mar; 20(1):81-6. PubMed ID: 15918553 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid neuron-specific enolase in non-selected patients. Finsterer J; Exner M; Rumpold H Scand J Clin Lab Invest; 2004; 64(6):553-8. PubMed ID: 15370460 [TBL] [Abstract][Full Text] [Related]
3. Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders? Blennow K; Wallin A; Ekman R J Neural Transm Park Dis Dement Sect; 1994; 8(3):183-91. PubMed ID: 7748462 [TBL] [Abstract][Full Text] [Related]
4. The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. Selakovic V; Raicevic R; Radenovic L J Clin Neurosci; 2005 Jun; 12(5):542-7. PubMed ID: 15921910 [TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid. Jacobi C; Reiber H Clin Chim Acta; 1988 Sep; 177(1):49-54. PubMed ID: 3052937 [TBL] [Abstract][Full Text] [Related]
6. Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children. Rodríguez-Núñez A; Cid E; Eirís J; Rodríguez-García J; Camiña F; Rodríguez-Segade S; Castro-Gago M Brain Dev; 1999 Jan; 21(1):16-9. PubMed ID: 10082247 [TBL] [Abstract][Full Text] [Related]
7. Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy. Tsukahara A; Hosokawa T; Nishioka D; Kotani T; Ishida S; Takeuchi T; Kimura F; Arawaka S Sci Rep; 2021 Nov; 11(1):22827. PubMed ID: 34819571 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen. Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population. Casmiro M; Maitan S; De Pasquale F; Cova V; Scarpa E; Vignatelli L; Eur J Neurol; 2005 May; 12(5):369-74. PubMed ID: 15804267 [TBL] [Abstract][Full Text] [Related]
10. Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? Schmitt B; Bauersfeld U; Schmid ER; Tuchschmid P; Molinari L; Fanconi S; Bandtlow C Brain Dev; 1998 Oct; 20(7):536-9. PubMed ID: 9840675 [TBL] [Abstract][Full Text] [Related]
11. Biochemical markers of cerebrospinal ischemia after repair of aneurysms of the descending and thoracoabdominal aorta. Anderson RE; Winnerkvist A; Hansson LO; Nilsson O; Rosengren L; Settergren G; Vaage J J Cardiothorac Vasc Anesth; 2003 Oct; 17(5):598-603. PubMed ID: 14579213 [TBL] [Abstract][Full Text] [Related]
12. Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease. Kohira I; Tsuji T; Ishizu H; Takao Y; Wake A; Abe K; Kuroda S Acta Neurol Scand; 2000 Dec; 102(6):385-7. PubMed ID: 11125754 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers of Brain Damage: S100B and NSE Concentrations in Cerebrospinal Fluid--A Normative Study. Hajduková L; Sobek O; Prchalová D; Bílková Z; Koudelková M; Lukášková J; Matuchová I Biomed Res Int; 2015; 2015():379071. PubMed ID: 26421286 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. Moritz S; Warnat J; Bele S; Graf BM; Woertgen C J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal-fluid lactate in adult mitochondriopathy with and without encephalopathy. Finsterer J Acta Med Austriaca; 2001; 28(5):152-5. PubMed ID: 11774778 [TBL] [Abstract][Full Text] [Related]
16. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures. Palmio J; Peltola J; Vuorinen P; Laine S; Suhonen J; Keränen T J Neurol Sci; 2001 Jan; 183(1):27-31. PubMed ID: 11166790 [TBL] [Abstract][Full Text] [Related]
17. Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia. Nooijen PT; Schoonderwaldt HC; Wevers RA; Hommes OR; Lamers KJ Dement Geriatr Cogn Disord; 1997; 8(3):169-73. PubMed ID: 9137895 [TBL] [Abstract][Full Text] [Related]
18. [Two cases of Creutzfeldt-Jakob disease with high neuron-specific enolase level in cerebrospinal fluid]. Jimi T; Wakayama Y; Shibuya S; Hara H; Sagawa F; Hashizume Y Rinsho Shinkeigaku; 1989 Jan; 29(1):118-21. PubMed ID: 2663293 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis]. Miyagami M; Tazoe M; Tsubokawa T No To Shinkei; 1989 Oct; 41(10):1021-7. PubMed ID: 2605041 [TBL] [Abstract][Full Text] [Related]
20. The fluctuations of neuron-specific enolase (NSE) levels of cerebrospinal fluid during bacterial meningitis: the relationship between the fluctuations of NSE levels and neurological complications or outcome. Inoue S; Takahashi H; Kaneko K Acta Paediatr Jpn; 1994 Oct; 36(5):485-8. PubMed ID: 7825447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]